New Drug for Chronic Myelogenous Leukemia?

Posted on April 20, 2005 by David Austin

A number of our clients have CML as a result of benzene exposure.  Many of them are on Gleevec and they find it very helpful.

A new compound may offer an alternative treatment for people with chronic myeloid leukemia (CML) who are resistant to treatment with the drug Gleevec, according to two studies presented at the annual meeting of the American Association for Cancer Research, in Anaheim, Calif.

Source:  Yahoo News

Tags:
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.benzeneleukemialawblog.com/admin/trackback/59041
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.